RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies
Kennedy’s autism report, touted by Trump, will suggest that using the pain reliever during pregnancy may be linked to the developmental disorder
Health Secretary Robert F. Kennedy Jr. plans to announce that pregnant women’s use of an over-the-counter pain medication is potentially linked to autism in a report that will also suggest a medicine derived from folate can be used to treat symptoms of the developmental disorder in some people, people familiar with the matter said.
The report, expected this month from the Department of Health and Human Services, is likely to highlight low levels of folate, an important vitamin, and Tylenol taken during pregnancy as well as other potential causes of autism, people familiar with the matter said.
Kennedy’s department also plans to pinpoint a form of folate known as folinic acid, or leucovorin, the people said, as a way to decrease the symptoms of autism, which affected roughly one in 31 eight-year-olds in the U.S. in 2022.
Tylenol, whose active ingredient is acetaminophen, is a widely used pain reliever, including by pregnant women. Some previous studies have indicated risks to fetal development, but others have found no association. The American College of Obstetricians and Gynecologists says it is safe to use in pregnancy, though it recommends pregnant women consult with their doctors before using it, as with all medicines.
Tylenol is made by McNeil Consumer Healthcare, a division of Kenvue, and other companies make similar acetaminophen-based products.
“Nothing is more important to us than the health and safety of the people who use our products,” a Kenvue spokeswoman said. “We have continuously evaluated the science and continue to believe there is no causal link between acetaminophen use during pregnancy and autism.”